NOVABAY PHARMACEUTICALS INC - COM (NBY)

CUSIP: 66987P102

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
2,665,765
Share change
+179,542
Total reported value
$1,679,000
Price per share
$0.63
Number of holders
19
Value change
+$108,538
Number of buys
9
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 66987P102?
CUSIP 66987P102 identifies NBY - NOVABAY PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVABAY PHARMACEUTICALS INC - COM (NBY) as of Q4 2014

As of 31 Dec 2014, NOVABAY PHARMACEUTICALS INC - COM (NBY) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,665,765 shares. The largest 10 holders included VANGUARD GROUP INC, GLENMEDE TRUST CO NA, WEDBUSH MORGAN SECURITIES INC, Orbitronix LP, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, GARRISON BRADFORD & ASSOCIATES INC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, DEUTSCHE BANK AG\, and GOLDMAN SACHS GROUP INC. This page lists 19 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.